Two Sigma Investments, LP Sio Gene Therapies Inc. Transaction History

Two Sigma Investments, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.28 - $0.41 $28 - $41	-100 Reduced 0.14%	70,925 $20,000
Q2 2022 Aug 15, 2022	SELL	$0.25 - $0.73 $6,105 - $17,827	-24,421 Reduced 25.59%	71,025 $26,000
Q1 2022 May 16, 2022	BUY	$0.55 - $1.47 $35,661 - $95,313	64,839 Added 211.84%	95,446 $64,000
Q4 2021 Feb 14, 2022	SELL	$1.29 - $2.36 $183,863 - $336,370	-142,530 Reduced 82.32%	30,607 $39,000
Q3 2021 Nov 15, 2021	SELL	$1.81 - $2.7 $347,981 - $519,088	-192,255 Reduced 52.62%	173,137 $376,000
Q2 2021 Aug 16, 2021	SELL	$2.07 - $2.89 $378,315 - $528,179	-182,761 Reduced 33.34%	365,392 $998,000
Q1 2021 May 17, 2021	BUY	$2.34 - $3.44 $1.28 Million - $1.89 Million	548,153 New	548,153 $1.43 Million

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.